RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2017 to Q4 2025

Type / Class
Equity / COM
Symbol
RYTM on Nasdaq
Shares outstanding
66,399,673
Price per share
$107.04
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
70,889,646
Total reported value
$7,159,045,368
% of total 13F portfolios
0.01%
Share change
+4,233,519
Value change
+$449,473,140
Number of holders
262
Price from insider filings
$107.04
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BAKER BROS. ADVISORS LP 8.9% $360,984,750 5,604,483 Baker Bros. Advisors LP 31 Mar 2025
RA CAPITAL MANAGEMENT, L.P. 8.7% $482,169,825 5,561,359 RA Capital Management, L.P. 30 Jun 2025
VANGUARD GROUP INC 7.5% $504,589,163 4,996,427 The Vanguard Group 30 Sep 2025
PERCEPTIVE ADVISORS LLC 6.8% $284,913,835 4,423,441 Perceptive Advisors LLC 31 Mar 2025
BlackRock, Inc. 6.9% $281,130,327 4,364,700 BlackRock, Inc. 31 Mar 2025
PRIMECAP MANAGEMENT CO/CA/ 6.4% -16% $430,506,130 -$62,126,826 4,262,859 -13% PRIMECAP MANAGEMENT CO/CA/ 30 Sep 2025
GOLDMAN SACHS GROUP INC 3% $117,157,406 1,818,932 THE GOLDMAN SACHS GROUP, INC. 31 Dec 2024

As of 30 Sep 2025, 262 institutional investors reported holding 70,889,646 shares of RHYTHM PHARMACEUTICALS, INC. - COM (RYTM). This represents 107% of the company’s total 66,399,673 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) together control 82% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 9.5% 6,302,215 +0.55% 0.01% $636,460,694
RA CAPITAL MANAGEMENT, L.P. 8.6% 5,681,359 +2.2% 7.1% $573,760,445
BAKER BROS. ADVISORS LP 8.4% 5,604,483 0% 4.1% $565,996,738
VANGUARD GROUP INC 7.5% 4,996,427 +39% 0.01% $504,589,163
PRIMECAP MANAGEMENT CO/CA/ 6.4% 4,262,859 -13% 0.33% $430,506,130
NEA Management Company, LLC 4.4% 2,909,956 0% 16% $293,876,456
PERCEPTIVE ADVISORS LLC 3.7% 2,438,969 +0.85% 7.2% $246,311,479
FMR LLC 3.2% 2,145,183 +9.8% 0.01% $216,642,009
STATE STREET CORP 3.1% 2,028,651 +6.3% 0.01% $204,873,464
GOLDMAN SACHS GROUP INC 2.9% 1,893,663 +9.2% 0.03% $191,241,026
FEDERATED HERMES, INC. 2.6% 1,727,885 +2.5% 0.31% $174,499,106
PRICE T ROWE ASSOCIATES INC /MD/ 2.1% 1,399,897 +4.4% 0.02% $141,377,000
Driehaus Capital Management LLC 2.1% 1,383,775 +9% 1% $139,747,437
GEODE CAPITAL MANAGEMENT, LLC 2.1% 1,362,829 +3.9% 0.01% $137,654,057
Polar Capital Holdings Plc 1.9% 1,244,932 -0.47% 0.61% $125,725,683
JPMORGAN CHASE & CO 1.8% 1,188,069 +52% 0.01% $119,983,088
JANUS HENDERSON GROUP PLC 1.7% 1,160,887 -18% 0.05% $117,237,978
WESTFIELD CAPITAL MANAGEMENT CO LP 1.6% 1,069,004 -34% 0.45% $107,958,714
ALKEON CAPITAL MANAGEMENT LLC 1.5% 1,017,700 0% 0.46% $102,777,523
ALLIANCEBERNSTEIN L.P. 1.5% 979,682 +1494% 0.03% $98,938,085
Checkpoint Capital L.P. 1.2% 763,707 -28% 26% $77,126,770
Rock Springs Capital Management LP 1.1% 717,102 -17% 4.2% $72,420,131
Pictet Asset Management Holding SA 1% 683,017 +64% 0.07% $68,952,135
Capital Research Global Investors 0.9% 598,247 0.01% $60,416,965
Woodline Partners LP 0.87% 580,183 +13% 0.28% $58,592,681

Institutional Holders of RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 60,771 $6,505,171 -$27,594,973 $107.04 15
2025 Q3 70,889,646 $7,159,045,368 +$449,473,140 $100.99 262
2025 Q2 66,543,505 $4,204,958,379 +$136,584,141 $63.19 225
2025 Q1 64,595,384 $3,424,910,613 -$18,829,096 $52.97 226
2024 Q4 64,917,500 $3,634,217,578 -$158,677,402 $55.98 202
2024 Q3 67,700,036 $3,546,202,706 -$85,917,668 $52.39 175
2024 Q2 69,300,680 $2,846,175,742 +$52,795,226 $41.06 164
2024 Q1 68,030,458 $2,946,208,413 +$55,358,404 $43.33 166
2023 Q4 66,696,112 $3,065,811,725 -$41,849,707 $45.97 167
2023 Q3 68,143,293 $1,562,080,292 +$58,456,223 $22.92 143
2023 Q2 66,212,640 $1,092,127,229 +$94,106,398 $16.49 116
2023 Q1 60,335,883 $1,076,382,910 -$49,077,961 $17.84 125
2022 Q4 62,378,764 $1,816,485,551 +$85,568,575 $29.12 116
2022 Q3 59,549,165 $1,446,896,472 +$426,232,319 $24.50 99
2022 Q2 45,934,145 $190,627,988 -$18,795,957 $4.15 82
2022 Q1 48,841,709 $562,605,977 +$4,688,818 $11.52 105
2021 Q4 48,449,400 $483,522,595 -$537,879 $9.98 94
2021 Q3 47,950,622 $626,233,206 +$2,428,146 $13.06 93
2021 Q2 42,614,232 $834,516,313 -$3,429,160 $19.58 101
2021 Q1 47,577,014 $1,011,965,096 +$147,271,703 $21.27 119
2020 Q4 40,510,233 $1,201,291,923 +$39,479,834 $29.73 114
2020 Q3 39,249,591 $850,611,960 -$43,710,727 $21.67 114
2020 Q2 41,237,373 $919,577,883 +$11,957,883 $22.30 89
2020 Q1 40,805,984 $621,064,603 -$34,159,931 $15.22 80
2019 Q4 42,379,694 $973,032,101 +$189,224,828 $22.96 89
2019 Q3 34,304,970 $740,632,813 +$64,825,672 $21.59 84
2019 Q2 31,264,637 $687,757,946 +$9,100,651 $22.00 83
2019 Q1 30,865,613 $846,116,903 -$21,936,591 $27.41 85
2018 Q4 31,656,641 $850,986,460 +$12,828,367 $26.88 73
2018 Q3 31,142,295 $908,421,537 +$2,062,008 $29.17 77
2018 Q2 31,030,594 $970,020,757 +$215,509,581 $31.26 84
2018 Q1 24,362,024 $405,654,613 -$5,856,715 $19.90 54
2017 Q4 21,624,878 $628,421,658 +$507,347,658 $29.06 65